Publications GFPC

Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study

Lien: https://doi.org/10.1177/17588359221099399

 

Télécharger : Atavax

 

Geoffroy Bilger , Anne-Claire Toffart, Marie Darrason, Michaël Duruisseaux, Lucie Ulmer, Pascal Wang, Etienne Giroux Leprieur, Nicolas Girard, Marie Ange Massiani, Paul Bore, Renaud Descourt, Julian Pinsolle, Solene Valery, Isabelle Monnet, Aurélie Swalduz, Claire Tissot, Pierre Fournel, Anne Baranzelli, Alexis B. Cortot and Chantal Decroisette

 

 

First‑line single‑agent pembrolizumab for PD‑L1‑positive (tumor proportion score ≥ 50%) advanced non‑small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)

 Lien: https://doi.org/10.1007/s00262-022-03232-2

Télécharger : Esceyp

Renaud Descourt, Laurent Greillier, Maurice Perol, Charles Ricordel, Jean‑Bernard Auliac, Lionel Falchero, Radj Gervais, Rémi Veillon, Sabine Vieillot, Florian Guisier, Marie Marcq, Grégoire Justeau, Laurence Bigay‑Game, Marie Bernardi, Pierre Fournel, Hélène Doubre, Julian Pinsolle, Karim Amrane, Christos Chouaïd, Chantal Decroisette

 

 

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

 

Télécharger : ROS1

 

Sébastien Gendarme, Olivier Bylicki, Christos Chouaid and Florian Guisier

First‑Line Treatment of Advanced Non‑Small‑Cell Lung Cancer with Immune‑Checkpoint Inhibitors: New Combinations and Long‑Term Data

Lien: https://doi.org/10.1007/s00262-021-03089-x

 

Télécharger : Article

 

Maxime Boussageon, Aurélie Swalduz, Christos Chouaïd, Olivier Bylicki

A definitive prognostication system for patients with thoracic malignancies diagnosed
with COVID-19: an update from the TERAVOLT registry.

Lien: https://doi.org/10.1016/j.jtho.2021.12.015

 

Télécharger :Teravolt

 

Jennifer G. Whisenant, Javier Baena, Alessio Cortellini, Li-Ching Huang, Giuseppe Lo Russo, Luca Porcu, Selina K. Wong, Christine M. Bestvina, Matthew D. Hellmann, Elisa Roca, Hira Rizvi, Isabelle Monnet, Amel Boudjemaa, Jacobo Rogado, Giulia Pasello, Natasha B. Leighl, Oscar Arrieta, Avinash Aujayeb, Ullas Batra, Ahmed Y. Azzam, Mojca Unk, Mohammed A. Azab, Ardak N. Zhumagaliyeva, Carlos GomezMartin, Juan B. Blaquier, Erica Geraedts, Giannis Mountzios, Gloria Serrano-Montero, Niels Reinmuth, Linda Coate, Melina Marmarelis, Carolyn J. Presley, Fred R. Hirsch, Pilar Garrido, Hina Khan, Alice Baggi, Celine Mascaux, Balazs Halmos, Giovanni L. Ceresoli, Mary J. Fidler, Vieri Scotti, Anne-Cécile Métivier, Lionel Falchero, Enriqueta Felip, Carlo Genova, Julien Mazieres, Umit Tapan, Julie Brahmer, Emilio Bria, Sonam Puri, Sanjay Popat, Karen L. Reckamp, Floriana Morgillo, Ernest Nadal, Francesca Mazzoni, Francesco Agustoni, Jair Bar, Federica Grosso, Virginie Avrillon, Jyoti D. Patel, Fabio Gomes, Ehab Ibrahim, Annalisa Trama, Anna C. Bettini, Fabrice Barlesi, Anne-Marie Dingemans, Heather Wakelee, Solange Peters, Leora Horn, Marina Chiara Garassino, Valter Torri, On behalf of the TERAVOLT study group

 

 

 

Immune-Checkpoint Inhibitors for Malignant Pleural Mesothelioma: A French, Multicenter, Retrospective Real-World Study

Lien: https://doi.org/10.3390/cancers14061498

 

Télécharger MesoImmun

 

Jean-Baptiste Assié , Florian Crépin, Emmanuel Grolleau, Anthony Canellas, Margaux Geier, Aude Grébert-Manuardi, Nabila Akkache, Aldo Renault, Pierre-Alexandre Hauss, Marielle Sabatini, Valentine Bonnefoy, Alexis Cortot, MarieWislez, Clément Gauvain, Christos Chouaïd, Arnaud Scherpereel and Isabelle Monnet

 

 

Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial

Lien : https://doi.org/10.1016/j.lungcan.2021.11.014

 

Télécharger IFCT-GFPC1101

 

Pierre-Jean Souquet, Clarisse Audigier-Valette, Olivier Molinier, Alexis Cortot, Jacques Margery, Lionel Moreau, Radj Gervais, Fabrice Barlesi, Eric Pichon, Gerard Zalcman, Patrick Dumont, Nicolas Girard, Michel Poudenx, Julien Mazieres, Jacques Cadranel, Didier Debieuvre, Jérôme Dauba, Alexandra Langlais, Franck Morin, Denis Moro-Sibilot, Virginie Westeel, Maurice Pérol

 

 

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 Study

Lien : https://doi.org/10.3390/cancers14071751

 

Télécharger BrigalK2

 

Renaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac, David Planchard, Bertrand Mennecier, Marie Wislez, Jacques Cadranel, Alexis Benjamin Cortot, Florian Guisier, Loïck Galland, Pascal Do, Roland Schott, Eric Dansin, Jennifer Arrondeau, Jean-Bernard Auliac, Margaux Geier and Christos Chouaïd